CVS will begin selling CBD topical products in its stores, but notably leaves out dietary supplement and functional foods.
Photo © iStockphoto.com/AlenaPaulus
Curaleaf Holdings, Inc. (Wakefield, MA) announced during an earnings call that it has developed an agreement with CVS Health Corp. to begin selling its CBD products in CVS stores. The products, which include creams, sprays, and lotions infused with CBD, will be sold in 800 stores across eight states, including California, Illinois, Colorado, and Alabama. Notably, however, the pharmacy chain will not be selling any CBD products marketed as dietary supplements or foods fortified with CBD. In addition to a lineup of CBD-based lotions, tinctures, and vape pens as part of its Curaleaf Hemp line, the company also manufactures medical-grade cannabis products for the legal marijuana markets, operating 40 marijuana dispensaries across 12 states.
Continuing innovation in algae-DHA: 2024 Natural Products Expo West Report
March 26th 2024At this year’s Natural Products Expo West, two brands have launched their own versions of algae DHA ingredients; FrieslandCampina and Aker BioMarine. Each brand showcased a different approach to the ingredient.